Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2025-12-26 @ 3:32 AM
NCT ID:
NCT05615220
Pre Assignment Details:
Participants with a diagnosis of Tourette's Disorder were enrolled in this study to receive oral ecopipam in an Open-label Stabilization Period and a Double-blind Randomized Withdrawal (R/WD) Period and then followed for safety up to 30 days post-last dose.
Recruitment Details:
The multicenter study was conducted globally in the United States, Bulgaria, Canada, Denmark, France, Germany, Hungary, Italy, Poland, Romania, Serbia, and Spain from 31 January 2023 to 04-February 2025.
Study:
NCT05615220
Study Brief:
Results Section:
NCT05615220